Consistently, treatment of MDA-MB-231 breast cancer cells with 3-HBI increased apoptotic cell death (Figure 6), accompanied by decreased Bcl-2 and significantly increased Bax expression (Figure 7). The gene discussed is BCL2; the disease is breast carcinoma.